Biodegradable and Bioabsorbable Stents Market

The Biodegradable and bioabsorbable stents are used for treating cardiovascular conditions pertaining to the coronary artery. These stents are also known as bioabsorbable or bioresorbable vascular scaffolds and are surgically placed in the coronary artery for eluting the drug that is administered for vascular restoration and the polymer coating. The biggest advantage of these stents is that they get entirely absorbed in the vessels over a period of time, reducing the risk of complications or infections.

Biodegradable and Bioabsorbable Stents Market contains market size and forecasts of Biodegradable and Bioabsorbable Stents in global, including the following market information:

Global Biodegradable and Bioabsorbable Stents Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Biodegradable and Bioabsorbable Stents Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Biodegradable and Bioabsorbable Stents companies in 2021 (%)

The global Biodegradable and Bioabsorbable Stents market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Polymer Based Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Biodegradable and Bioabsorbable Stents include Abbott Laboratories, Kyoto Medical Planning, Reva Medical, Elixir Medical Corporation, Amaranth Medical, Terumo Corporation, Arterius Limited, Biotronik and Meril Life Sciences and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Biodegradable and Bioabsorbable Stents manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Biodegradable and Bioabsorbable Stents Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biodegradable and Bioabsorbable Stents Market Segment Percentages, by Type, 2021 (%)

Polymer Based

Metal Based

Global Biodegradable and Bioabsorbable Stents Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biodegradable and Bioabsorbable Stents Market Segment Percentages, by Application, 2021 (%)

Coronary Artery Disease

Peripheral Artery Disease

Global Biodegradable and Bioabsorbable Stents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Biodegradable and Bioabsorbable Stents Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Biodegradable and Bioabsorbable Stents revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Biodegradable and Bioabsorbable Stents revenues share in global market, 2021 (%)

Key companies Biodegradable and Bioabsorbable Stents sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Biodegradable and Bioabsorbable Stents sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott Laboratories

Kyoto Medical Planning

Reva Medical

Elixir Medical Corporation

Amaranth Medical

Terumo Corporation

Arterius Limited

Biotronik

Meril Life Sciences

Xenogenics Corporation